Literature DB >> 19497084

Too much ado about instrumental variable approach: is the cure worse than the disease?

Onur Baser1.   

Abstract

OBJECTIVE: To review the efficacy of instrumental variable (IV) models in addressing a variety of assumption violations to ensure standard ordinary least squares (OLS) estimates are consistent. IV models gained popularity in outcomes research because of their ability to consistently estimate the average causal effects even in the presence of unmeasured confounding. However, in order for this consistent estimation to be achieved, several conditions must hold. In this article, we provide an overview of the IV approach, examine possible tests to check the prerequisite conditions, and illustrate how weak instruments may produce inconsistent and inefficient results.
METHODS: We use two IVs and apply Shea's partial R-square method, the Anderson canonical correlation, and Cragg-Donald tests to check for weak instruments. Hall-Peixe tests are applied to see if any of these instruments are redundant in the analysis.
RESULTS: A total of 14,952 asthma patients from the MarketScan Commercial Claims and Encounters Database were examined in this study. Patient health care was provided under a variety of fee-for-service, fully capitated, and partially capitated health plans, including preferred provider organizations, point of service plans, indemnity plans, and health maintenance organizations. We used controller-reliever copay ratio and physician practice/prescribing patterns as an instrument. We demonstrated that the former was a weak and redundant instrument producing inconsistent and inefficient estimates of the effect of treatment. The results were worse than the results from standard regression analysis.
CONCLUSION: Despite the obvious benefit of IV models, the method should not be used blindly. Several strong conditions are required for these models to work, and each of them should be tested. Otherwise, bias and precision of the results will be statistically worse than the results achieved by simply using standard OLS.

Entities:  

Mesh:

Year:  2009        PMID: 19497084     DOI: 10.1111/j.1524-4733.2009.00567.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  7 in total

1.  Applying propensity score methods in medical research: pitfalls and prospects.

Authors:  Zhehui Luo; Joseph C Gardiner; Cathy J Bradley
Journal:  Med Care Res Rev       Date:  2010-05-04       Impact factor: 3.929

2.  Instrumental variable meta-analysis of individual patient data: application to adjust for treatment non-compliance.

Authors:  Branko Miladinovic; Ambuj Kumar; Iztok Hozo; Benjamin Djulbegovic
Journal:  BMC Med Res Methodol       Date:  2011-04-21       Impact factor: 4.615

3.  Coronary angiography utilization and costs for coronary artery bypass graft surgery patients in Turkey.

Authors:  Onur Baser; Abdulkadir Burkan; Erdem Baser; Rasim Koselerli; Emre Ertugay; Akif Altinbas
Journal:  Cardiol Ther       Date:  2013-06-27

4.  Can your house keep you out of a nursing home?

Authors:  Maaike Diepstraten; Rudy Douven; Bram Wouterse
Journal:  Health Econ       Date:  2020-01-31       Impact factor: 3.046

5.  Severity index for rheumatoid arthritis and its association with health care costs and biologic therapy use in Turkey.

Authors:  Onur Baser; Erdem Baser; Akif Altinbas; Abdulkadir Burkan
Journal:  Health Econ Rev       Date:  2013-03-12

6.  An international comparison of deceased and living organ donation/transplant rates in opt-in and opt-out systems: a panel study.

Authors:  Lee Shepherd; Ronan E O'Carroll; Eamonn Ferguson
Journal:  BMC Med       Date:  2014-09-24       Impact factor: 11.150

7.  Leveraging methylation to identify the potential causal genes associated with survival in lung adenocarcinoma and lung squamous cell carcinoma.

Authors:  Lu Liu; Ping Zeng; Sheng Yang; Zhongshang Yuan
Journal:  Oncol Lett       Date:  2020-04-22       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.